Consolidated figures · ₹ crore
| ₹ Cr | Mar 2026 |
|---|---|
| Revenue | 801 |
| COGS | 92 |
| Gross profit | 710 |
| 360 | |
| 349 | |
| OPM % | 43.6% |
| Depreciation | 48 |
| Interest | 13 |
| 9 | |
| Profit before tax | 297 |
| Tax | 76 |
| Tax % | 25.5% |
| PAT | 222 |
| PAT margin % | 27.7% |
| EPS (₹) | 17.8 |
| EPS adjusted (₹) | 17.9 |
| 25.2% |
| ₹ Cr | Mar 2026 |
|---|---|
| Equity capital | 25 |
| Reserves | 442 |
| 0 | |
| 207 | |
| Total equity & liabilities | 674 |
| 179 | |
| CWIP | 2 |
| Investments | 110 |
| 384 | |
| Total assets | 674 |
| ₹ Cr | Mar 2026 |
|---|---|
| 254 | |
| -202 | |
| -59 | |
| Net cash flow | -7 |
| Free cash flow | 220 |
| CFO / Operating profit % | 72.6% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Ayurvedic products/ medicines | 415.69 | 164.57 | 0 | 0 |
| Ayurvedic healthcare services | 383.4 | 156.36 | 0 | 0 |
| Others | 2.27 |
| 2.27 |
| 0 |
| 0 |
₹ crore by fiscal year